GlassScriptPhysician profile
John D Odette
NPI 1124224464
$10,294.95
in general payments reported to CMS, 2019-2025
29 companies · $2,750 in 2025
The $2,750 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,124 · 2020: $737 · 2021: $2,311 · 2022: $854 · 2023: $988 · 2024: $1,530 · 2025: $2,750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,837 · Consulting Fee: $1,269 · Entertainment: $144 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,837.08 |
| Consulting Fee | $1,269.00 |
| Entertainment | $144.43 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $3,347.74 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, One Series Ultra |
| Astrazeneca Pharmaceuticals LP | $1,269.00 | 2025 | |
| Alcon Vision LLC | $1,163.99 | 2019-2025 | Clareon, Centurion, Clareon Panoptix Pro |
| Abbvie INC. | $1,050.50 | 2022-2025 | |
| Rxsight INC | $783.32 | 2021-2025 | Rxsight Contact Lens, Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Allergan, INC. | $704.90 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $395.82 | 2022-2025 | Envista Mx60 Iol, Envista Envy Iol, Miebo |
| Novartis Pharmaceuticals Corporation | $194.95 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $166.01 | 2021 | |
| Biotissue Holdings INC. | $144.75 | 2022-2023 | |
| Optos, INC. | $144.43 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Mallinckrodt Enterprises LLC | $139.15 | 2019 | |
| Horizon Therapeutics Plc | $124.40 | 2022 | |
| Sun Pharmaceutical Industries INC. | $105.95 | 2019-2022 | |
| Biosense Webster, INC. | $92.95 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $72.22 | 2023-2024 | |
| Aerie Pharmaceuticals, INC. | $57.10 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $52.38 | 2024 | Xdemvy |
| New World Medical,INC. | $50.04 | 2019-2022 | |
| Glaukos Corporation | $45.48 | 2024-2025 | Kxl System (Not Refurbished), Ce-Marked Kxla System |
| Thea Pharma INC. | $27.42 | 2023-2024 | Iyuzeh |
| Mallinckrodt Hospital Products INC. | $24.60 | 2020 | |
| Oyster Point Pharma, INC. | $23.45 | 2022 | |
| Dompe US, INC. | $22.28 | 2022 | |
| Shire North American Group INC | $19.87 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Ocular Therapeutix, INC. | $18.73 | 2019 | |
| Sight Sciences, INC. | $17.82 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $16.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Odette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.